Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid.

导出 LinkOut

翻译打印收藏纠错

作者： Chuntian,Hong ^[1] ; Yonghao,Yan ^[1] ; Liyang,Su ^[1] ; Debo,Chen ^[2] ; Changqing,Zhang ^[3]

作者单位： Department of Ultrasound, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou 362000, China. ^[1] Department of Breast Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou 362000, China. ^[2] Department of Gastroenterology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou 362000, China. ^[3]

关键词 breast cancer non-alcoholic fatty liver disease non-alcoholic fatty pancreas disease risk-stratification scoring system uric acid

DOI 10.1515/med-2022-0462

PMID 35434374

发布时间 2022-04-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Open medicine (Warsaw, Poland)

2022年17卷1期

619-625页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid.

Open medicine (Warsaw, Poland)

相似文献

Open medicine (Warsaw, Poland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid.

Open medicine (Warsaw, Poland)

相似文献

Open medicine (Warsaw, Poland)

相关期刊

检索历史清除